APA (7th ed.) Citation

Treon, S. P., Kotton, C. N., Park, D. J., Moranzoni, G., Lemvigh, C. K., Gathe, J. C., . . . Dhakal, B. A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: Immune biomarker and clinical findings. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Treon, Steven P., et al. A Randomized, Placebo-controlled Trial of the BTK Inhibitor Zanubrutinib in Hospitalized Patients with COVID-19 Respiratory Distress: Immune Biomarker and Clinical Findings. Frontiers Media S.A.

MLA (9th ed.) Citation

Treon, Steven P., et al. A Randomized, Placebo-controlled Trial of the BTK Inhibitor Zanubrutinib in Hospitalized Patients with COVID-19 Respiratory Distress: Immune Biomarker and Clinical Findings. Frontiers Media S.A.